National Biosafety Authority approves HIV vaccine trial

By NATION REPORTER

THE National Biosafety Authority (NBA) has approved a clinical trial of an HIV vaccine by the Centre for Health Research in Zambia (CFHRZ).

The NBA Board, during its extra ordinary meeting held last week, approved the vaccine trial permit application for CFHRZ.

This is according to a statement issued yesterday by Sandra Lombe, the NBA Communications Officer.

“The experimental medicine vaccine trial will be administered to People Living with HIV CLICK HERE TO READ MORE 

Author